FrancophonIA/ELRC3.0 huggingface dataset:
English: How much KOGENATE Bayer you should use and how often you should use it depends on many factors such as:
Croatian: Količina i učestalost uzimanja lijeka KOGENATE Bayer ovise o brojnim čimbenicima kao što su:
English: Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med 2013; 368: 231-9.http://www.bloodjournal.org/content/121/20/4046.full.pdf study, the FranceCoag study also found no statistically significant increased risk for any rFVIII products vs Advate when French patients (also in the RODIN/Pednet study) were excluded.
Croatian: Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med 2013; 368: 231-9. - http://www.bloodjournal.org/content/121/20/4046.full.pdf
English: For major surgery in particular, close monitoring of the substitution therapy by means of coagulation analysis must be carried out.
Croatian: Pozorno praćenje nadomjesnog liječenja analizom koagulacije nužno je osobito u slučaju opsežnih kirurških zahvata.
English: 1 venipuncture set
Croatian: 1 set za venepunkciju
English: Differences between products in each FVIII class and consequently differential risks between individual products, are biologically plausible.
Croatian: Biološki je vjerojatno da postoje različitosti između lijekova u svakom razredu lijekova s faktorom VIII te slijedom toga i razlike u rizicima između pojedinih lijekova.
English: Be sure that the powder is completely dissolved.
Croatian: Prije upotrebe provjerite je li se sav prašak rastopio.
English: 250 IU (octocog alfa) (100 IU/mL after reconstitution).
Croatian: 250 IU oktokoga alfa (100 IU/ml nakon pripreme za primjenu).
English: 500 IU (octocog alfa) (200 IU/mL after reconstitution).
Croatian: 500 IU oktokoga alfa (200 IU/ml nakon pripreme za primjenu).
English: KOGENATE Bayer 3000 IU contains (3000 IU / 5 mL) = 600 IU octocog alfa per mL after reconstitution.
Croatian: KOGENATE Bayer 3000 IU sadržava (3000 IU / 5 ml) = 600 IU oktokoga alfa po ml nakon pripreme za primjenu.
English: KOGENATE Bayer 250 IU powder and solvent for solution for injection KOGENATE Bayer 500 IU powder and solvent for solution for injection KOGENATE Bayer 1000 IU powder and solvent for solution for injection KOGENATE Bayer 2000 IU powder and solvent for solution for injection KOGENATE Bayer 3000 IU powder and solvent for solution for injection
Croatian: KOGENATE Bayer 250 IU prašak i otapalo za otopinu za injekciju KOGENATE Bayer 500 IU prašak i otapalo za otopinu za injekciju KOGENATE Bayer 1000 IU prašak i otapalo za otopinu za injekciju KOGENATE Bayer 2000 IU prašak i otapalo za otopinu za injekciju KOGENATE Bayer 3000 IU prašak i otapalo za otopinu za injekciju
English: • The SIPPET study was not designed to evaluate the risk of inhibitor development for individual products, and included a limited number of FVIII products.
Croatian: • Ispitivanje SIPPET nije osmišljeno za procjenu rizika od razvoja inhibitora kod pojedinih lijekova te je uključivalo ograničen broj lijekova s faktorom VIII.
English: KOGENATE Bayer 2000 IU contains (2000 IU / 5 mL) = 400 IU octocog alfa per mL after reconstitution.
Croatian: KOGENATE Bayer 2000 IU sadržava (2000 IU / 5 ml) = 400 IU oktokoga alfa po ml nakon pripreme za primjenu.
English: 3000 IU (octocog alfa) (600 IU/mL after reconstitution).
Croatian: 3000 IU oktokoga alfa (600 IU/ml nakon pripreme za primjenu).
English: The doctor should always adjust the dose and the frequency of administration according to your individual needs.
Croatian: Količinu i učestalost primjene ovog lijeka liječnik uvijek mora odrediti prema potrebama pojedinačnog bolesnika.
English: KOGENATE Bayer 500 IU contains (500 IU / 2.5 mL) = 200 IU octocog alfa per mL after reconstitution.
Croatian: KOGENATE Bayer 500 IU sadržava (500 IU / 2,5 ml) = 200 IU oktokoga alfa po ml nakon pripreme za primjenu.
English: It is important to use the venipuncture set provided with the product for administration as it incorporates an in-line filter.
Croatian: Za primjenu je važno uporabiti komplet za venepunkciju priložen uz lijek, jer je u njega ugrađen filter.
English: 1000 IU (octocog alfa) (400 IU/mL after reconstitution).
Croatian: 1000 IU oktokoga alfa (400 IU/ml nakon pripreme za primjenu).
English: KOGENATE Bayer 1000 IU contains (1000 IU / 2.5 mL) = 400 IU octocog alfa per mL after reconstitution.
Croatian: KOGENATE Bayer 1000 IU sadržava (1000 IU / 2,5 ml) = 400 IU oktokoga alfa po ml nakon pripreme za primjenu.
English: These therapies should be directed by physicians with experience in the care of patients with haemophilia.
Croatian: Takvo liječenje može voditi liječnik s iskustvom u liječenju bolesnika s hemofilijom.
English: Slovenská republika Bayer spol.
Croatian: Slovenská republika Bayer spol. s r.o.
English: The possibility of allergic reactions to substances contained in this medication, e.g. trace amounts of mouse and hamster protein exists in certain predisposed patients.
Croatian: U nekih bolesnika s predispozicijom postoji mogućnost alergijskih reakcija na tvari prisutne u lijeku, npr. bjelančevine miša i hrčka koje su prisutne u tragovima.
English: 2000 IU (octocog alfa) (400 IU/mL after reconstitution).
Croatian: 2000 IU oktokoga alfa (400 IU/ml nakon pripreme za primjenu).
English: If bleeding is not controlled
Croatian: U slučaju neuspješnog zaustavljanja krvarenja
English: The findings from the SIPPET study, as well as those from the individual clinical trials and observational studies, are not sufficient to confirm any consistent statistically and clinically meaningful differences in inhibitor risk between the rFVIII and pdFVIII product classes.
Croatian: Nalazi ispitivanja SIPPET, kao i nalazi pojedinih kliničkih i opservacijskih ispitivanja nisu dostatni kako bi potvrdili bilo kakve statistički dosljedne i klinički značajne razlike u pogledu rizika od inhibitora između razreda lijekova s rekombinantnim faktorom VIII i lijekova s faktorom VIII dobivenim iz plazme.
English: Inspect visually for particulate matter and discoloration prior to administration.
Croatian: Prije primjene vizualno provjerite na prisutnost čestica i promjenu boje.
English: Specifically, the findings from the SIPPET study, as well as those from the individual clinical trials and observational studies included in the MAH responses, are not sufficient to confirm any consistent statistically and clinically meaningful differences in inhibitor risk between the rFVIII and pdFVIII product classes.
Croatian: Točnije, nalazi ispitivanja SIPPET, kao i nalazi pojedinih kliničkih i opservacijskih ispitivanja navedeni u odgovorima nositelja odobrenja za stavljanje u promet nisu dostatni kako bi potvrdili bilo kakve statistički dosljedne i klinički značajne razlike u pogledu rizika od inhibitora između razreda lijekova s rekombinantnim faktorom VIII i lijekova s faktorom VIII dobivenim iz plazme.
English: How to store KOGENATE Bayer
Croatian: Kako primjenjivati KOGENATE Bayer
English: Puncture the vein and secure the venipuncture set with a plaster.
Croatian: Probijte stijenku vene te pričvrstite set za venepunkciju flasterom.
English: How KOGENATE Bayer is given
Croatian: Kako se daje Kogenate Bayer
English: Detailed instructions for reconstitution and administration of KOGENATE Bayer using vial with reconstitution cap (Bio-Set System): Wash your hands thoroughly using soap and warm water.
Croatian: Detaljne upute za pripremu za primjenu i primjenu lijeka KOGENATE Bayer uz primjenu bočice sa zatvaračem za pripremu (Bio-Set sustav):
English: The RODIN/Pednet study3 also found no evidence of a class difference in inhibitor risk between all pdFVIII vs all rFVIII; for ‘clinically relevant' inhibitors the adjusted hazard ratio was 0.96 (95% CI 0.62-1.49), and for high titre inhibitors (≥5 BU/ml) was 0.95 (95% CI 0.56-1.61).
Croatian: Za „klinički relevantne” inhibitore prilagođeni omjer rizika bio je 0,96 (95% CI 0,62 do 1,49), a za inhibitore visokog titra (≥ 5 BU(ml) bio je 0,95 (95 % CI 0,56 do 1,61).
English: Unscrew the syringe to disconnect the vial (I).
Croatian: Odvijte štrcaljku da biste odvojili bočicu (I).
English: • The PRAC noted that the efficacy and safety of Factor VIII products as indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A have been established.Based on the available data, the PRAC considered that SmPC updates for the FVIII products are warranted: section 4.4 should be amended to include a warning on the clinical importance of monitoring patients for FVIII inhibitor development.
Croatian: • PRAC je napomenuo da je utvrđena djelotvornost i sigurnost lijekova s faktorom VIII koji su indicirani za liječenje i profilaksu krvarenja u bolesnika s hemofilijom A.
English: • One mL KOGENATE Bayer 3000 IU contains approximately 600 IU (3000 IU / 5 mL) of recombinant human coagulation factor VIII (INN: octocog alfa) after reconstitution with water for injections.
Croatian: • Jedan ml KOGENATE Bayer 3000 IU nakon rekonstitucije s vodom za injekcije sadrži približno 600 IU (3000 IU / 5 ml) ljudskog koagulacijskog faktora VIII (INN: oktokog alfa).
English: PHARMACEUTICAL FORM Powder and solvent for solution for injection (vial adapter).
Croatian: Prašak i otapalo za otopinu za injekciju (nastavak za bočicu).
English: • One mL KOGENATE Bayer 250 IU contains approximately 100 IU (250 IU / 2.5 mL) of recombinant human coagulation factor VIII (INN: octocog alfa) after reconstitution with water for injections.
Croatian: • Jedan ml KOGENATE Bayer 250 IU nakon rekonstitucije s vodom za injekcije sadrži približno 100 IU (250 IU / 2,5 ml) ljudskog koagulacijskog faktora VIII (INN: oktokog alfa).
English: • syringe plunger rod
Croatian: • osip/osip praćen svrbežom
English: Table 3: Frequency of adverse drug reactions MedDRA
Croatian: Tablica 3: Učestalost nuspojava MedDRA standardna klasifikacija prema organskim sustavima
English: • the severity of your haemophilia
Croatian: • stupanj hemofilije
English: • One mL KOGENATE Bayer 1000 IU contains approximately 400 IU (1000 IU / 2.5 mL) of recombinant human coagulation factor VIII (INN: octocog alfa) after reconstitution with water for injections.
Croatian: • Jedan ml KOGENATE Bayer 1000 IU nakon rekonstitucije s vodom za injekcije sadrži približno 400 IU (1000 IU / 2,5 ml) ljudskog koagulacijskog faktora VIII (INN: oktokog alfa).
English: • One mL KOGENATE Bayer 2000 IU contains approximately 400 IU (2000 IU / 5 mL) of recombinant human coagulation factor VIII (INN: octocog alfa) after reconstitution with water for injections.
Croatian: • Jedan ml KOGENATE Bayer 2000 IU nakon rekonstitucije s vodom za injekcije sadrži približno 400 IU (2000 IU / 5 ml) ljudskog koagulacijskog faktora VIII (INN: oktokog alfa).
English: • One mL KOGENATE Bayer 500 IU contains approximately 200 IU (500 IU / 2.5 mL) of recombinant human coagulation factor VIII (INN: octocog alfa) after reconstitution with water for injections.
Croatian: • Jedan ml KOGENATE Bayer 500 IU nakon rekonstitucije s vodom za injekcije sadrži približno 200 IU (500 IU / 2,5 ml) ljudskog koagulacijskog faktora VIII (INN: oktokog alfa).
English: Inject the solvent into the vial containing the powder by slowly pushing the syringe plunger down (F).
Croatian: Polagano potiskujte klip štrcaljke te ubrizgajte otapalo u bočicu s praškom (F).
English: • one vial plus Bio-Set system, containing powder (10 mL clear glass type 1 vial with latex-free grey halogenobutyl rubber blend stopper plus transfer system with protective cap [Bio-Set])
Croatian: • jednu bočicu sa sustavom Bio-Set s praškom (10-mililitarska bočica od prozirnog stakla tipa 1
English: 1 F. Peyvandi et al. “A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A” N Engl J Med. 2016 May 26;374(21):2054-64)
Croatian: “A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A” N Engl J Med.
English: You are filtering by using the vial adapter.
Croatian: Filtrirajte uz pomoć nastavka za bočicu.
English: Apply a tourniquet to your arm 13.
Croatian: Za to koristite novu štrcaljku te je priključite na komplet za venepunkciju.
English: Class
Croatian: Učestalost
English: Eligible
Croatian: TVARI
English: Very
Croatian: SAD
English: Do not shake vial.
Croatian: Ne tresite bočicu.
English: The aPTT is prolonged in all haemophiliacs.
Croatian: U oboljelih od hemofilije APTV je uvijek produljen.
English: Do not refrigerate the solution after reconstitution.
Croatian: Nemojte koristiti nakon tog datuma.
English: These treatments should be prescribed by doctors with experience in the care of patients with haemophilia A. Speak to your doctor if you would like further information on this.
Croatian: Ovakvo liječenje moraju propisati liječnici s iskustvom u liječenju oboljelih od hemofilije A.
English: • Inhibitor development is an identified risk with both pdFVIII and rFVIII products.
Croatian: • Utvrđen je rizik od razvoja inhibitora kod lijekova s faktorom VIII dobivenim iz plazme i lijekova s rekombinantnim faktorom VIII.
English: Attach the pre-filled syringe to the threaded vial adapter by turning clockwise (F).
Croatian: Okretanjem u smjeru kazaljke na satu pričvrstite napunjenu štrcaljku na nastavak za bočicu s navojima (F).
English: initiation pack: 14 tablets + 14 tablets + 14 tablets +14 tablets
Croatian: pakovanje za početak liječenja: 14 tableta + 14 tableta + 14 tableta +14 tableta
English: Thyme EMA/307113/2016
Croatian: EMA/307113/2016
English: Stomach problems may occur.
Croatian: Mogući su želučani problemi.
English: Thymus vulgaris L. and Thymus zygis L., herba
Croatian: Thymus vulgaris L. i Thymus zygis L., herba
English: Most thyme preparations should only be used in adults and adolescents over the age of 12 years, but a few can also be used in children above 4 years.
Croatian: Većinu pripravaka timijanove zeleni smiju uzimati samo odrasle osobe i adolescenti stariji od 12 godina, no neke od njih mogu uzimati i djeca starija od 4 godine.
English: In its assessment, the HMPC also considered clinical studies in both adults and children.
Croatian: Prilikom svoje ocjene HMPC je razmotrio i klinička ispitivanja na odraslima i djeci.
English: If symptoms last longer than one week or worsen during the use of the medicine, a doctor or a qualified healthcare practitioner should be consulted.
Croatian: Ako simptomi traju dulje od jednog tjedna ili se pogoršaju tijekom primjene, potrebno je obratiti se liječniku ili kvalificiranom
English: Although no significant difference was observed between thyme and bromhexine in treating the cough, there were shortcomings in the study such as the small number of patients and lack of details of the thyme preparation, so firm conclusions could not be drawn.
Croatian: Iako nije zabilježena značajna razlika u liječenju kašlja timijanovom zeleni i bromheksinom, postojali su nedostatci u ispitivanju, primjerice mali broj bolesnika i manjak pojedinosti o pripravku timijanove zeleni, tako da nije bilo moguće doći do pouzdanih zaključaka.
English: The solvent is then partially or completely evaporated to obtain a soft or dry extract.
Croatian: Otapalo se zatim djelomično ili u potpunosti uparava kako bi se dobio gusti ili suhi ekstrakt.
English: The HMPC conclusions only cover thyme preparations which are obtained by drying and comminuting (reducing into tiny pieces) the leaves and flowers, by expressing the juice of the leaves and flowers or as dry, liquid and soft extracts.
Croatian: Zaključcima HMPC-a obuhvaćeni su samo pripravci timijanove zeleni koji su dobiveni sušenjem i usitnjavanjem (smanjivanjem na manje komadiće) lišća i cvjetova, istiskivanjem soka iz lišća i cvjetova ili u obliku suhih, tekućih i gustih ekstrakata.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom20 September 2016 EMA/307113/2016
Croatian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● Ujedinjena Kraljevina
English: What is thyme?
Croatian: Što je timijanova zelen?
English: Further information on the HMPC assessment of thyme medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Croatian: Daljnje informacije o HMPC-ovoj ocjeni lijekova koji sadrže timijanovu zelen, uključujući pojedinosti zaključaka Povjerenstva, mogu se pronaći pod karticom „All documents” na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Thyme is the common name for the leaves and flowers of the plants Thymus vulgaris L. or Thymus zygis L.
Croatian: Timijanova zelen je uobičajen naziv za lišće i cvjetove biljaka Thymus vulgaris L. ili Thymus zygis L.
English: This summary is not intended to provide practical advice on how to use medicines containing thyme.
Croatian: Svrha ovog sažetka nije davati praktične savjete o načinu primjene lijekova koji sadrže timijanovu zelen.
English: Further information on the risks associated with these thyme medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Croatian: Više o rizicima povezanim s ovim lijekovima koji sadrže timijanovu zelen, uključujući odgovarajuće mjere opreza za njihovu sigurnu primjenu, možete pronaći u monografiji pod karticom „All documents” na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Any applications for the licensing of medicines containing thyme have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Croatian: Svi zahtjevi za odobrenje lijekova koji sadrže timijanovu zelen moraju se podnijeti nacionalnim tijelima nadležnima za lijekove, koja ocjenjuju zahtjev za biljni lijek i uzimaju u obzir znanstvene zaključke HMPC-a.
English: Thyme medicines must not be used in patients who are allergic to thyme or to other plants of the Lamiaceae (Labiatae) family.
Croatian: Lijekovi koji sadrže timijanovu zelen ne smiju se primjenjivati u bolesnika koji su alergični na timijanovu zelen ili druge biljke iz porodice Lamiaceae (Labiatae).
English: Herbal medicines containing these thyme preparations are usually available as herbal tea to be drunk or in liquid or solid forms to be taken by mouth.
Croatian: Biljni lijekovi koji sadrže te pripravke timijanove zeleni najčešće su dostupni kao biljni čaj koji se pije ili u tekućem ili krutom obliku za uzimanje kroz usta.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing thyme.
Croatian: Države članice EU-a uzimaju u obzir zaključke HMPC-a prilikom ocjene zahtjeva za davanje odobrenja za biljne lijekove koji sadrže timijanovu zelen.
English: Information on the use and licensing of thyme medicines in EU Member States should be obtained from the relevant national authorities.
Croatian: Informacije o primjeni i davanju odobrenja za lijekove koji sadrže timijanovu zelen u državama članicama EU-a mogu se dobiti od nadležnih nacionalnih tijela.
English: Other information about thyme medicines
Croatian: Ostale informacije o lijekovima koji sadrže timijanovu zelen
English: Detailed instructions on how to take thyme medicines and who can use them can be found in the package leaflet that comes with the medicine.
Croatian: Detaljne upute o načinu uzimanja lijekova koji sadrže timijanovu zelen i o tome tko ih smije uzimati navedene su u uputi o lijeku koja je priložena uz lijek.
English: The HMPC conclusions on the use of these thyme medicines for productive coughs are based on their ‘traditional use'.
Croatian: Zaključci HMPC-a o primjeni ovih lijekova koji sadrže timijanovu zelen za produktivan kašalj temelje se na njihovoj „tradicionalnoj primjeni”.
English: A clinical study involving 60 adults with productive cough treated either with a thyme preparation or bromhexine, an established treatment for productive coughs.
Croatian: U kliničkom ispitivanju provedenom na 60 odraslih osoba produktivan kašalj liječen je pripravkom timijanove zeleni ili bromheksinom, poznatim lijekom za liječenje produktivnog kašlja.
English: Thyme preparations may also be found in combination with other herbal substances in some herbal medicines.
Croatian: Pripravci timijanove zeleni mogu postojati također i u kombinaciji s drugim biljnim tvarima u nekim biljnim lijekovima.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of thyme.
Croatian: Ovaj dokument predstavlja sažetak znanstvenih zaključaka Povjerenstva za biljne lijekove (HMPC) u pogledu medicinske primjene timijanove zeleni.
English: What are the risks associated with thyme medicines?
Croatian: Koji su rizici povezani s lijekovima koji sadrže timijanovu zelen?
English: The HMPC concluded that, on the basis of its long-standing use, these thyme preparations can be used for productive (chesty) coughs associated with colds.
Croatian: Na temelju dugotrajne primjene, HMPC je zaključio da se ovi pripravci timijanove zeleni mogu koristiti za produktivan (vlažni) kašalj uslijed prehlade.
English: For more information about treatment with thyme medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Croatian: Za više informacija o liječenju lijekovima koji sadrže timijanovu zelen pročitajte uputu o lijeku priloženu uz lijek, odnosno obratite se svom liječniku ili ljekarniku.
English: For practical information about using thyme medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Croatian: Za praktične informacije o primjeni lijekova koji sadrže timijanovu zelen bolesnici trebaju pročitati uputu o lijeku priloženu uz lijek, odnosno obratiti se svom liječniku ili ljekarniku.
English: Therefore, the HMPC conclusions on the use of these thyme medicines are based on their longstanding use.
Croatian: Zaključci HMPC-a o lijekovima koji sadrže timijanovu zelen stoga se temelje na njihovoj dugotrajnoj primjeni.
English: What evidence supports the use of thyme medicines?
Croatian: Kojim se dokazima potkrjepljuje primjena lijekova koji sadrže timijanovu zelen?
English: How are thyme medicines approved in the EU?
Croatian: Kako se u EU-u odobravaju lijekovi koji sadrže timijanovu zelen?
English: Protect from light.
Croatian: Zaštititi od svijetla.
English: Date of first authorisation: 15/06/2012.
Croatian: Datum prvog odobrenja: 15/06/2012.
English: The recommended volume for 1 dose is between 0.1 and 0.5 ml.
Croatian: Preporučena količina za jednu dozu je između 0,1 i 0,5 ml.
English: Lot{number}
Croatian: Lot {broj}
English: The aim is to give every bird one dose of vaccine.
Croatian: Cilj je dati svakom piliću jednu dozu cjepiva.
English: One dose contains:
Croatian: Jedna doza sadržava:
English: Date of latest renewal: 15/05/2017.
Croatian: Datum posljednjeg odobrenja: 15/05/2017.
English: Zero days.
Croatian: 0 dana.
English: No information is available on the influence of high levels of maternally derived antibodies on the efficacy.
Croatian: Nema dostupnih informacija o utjecaju visokih koncentracija maternalnih antitijela na učinkovitost.
English: 2000 Rockford Road, Charles City
Croatian: 2000 Rockford Road, Charles City IA 50616
English: In drinking water use:
Croatian: Upotreba u vodi za piće:
English: Disinfect hands and equipment after use.
Croatian: Nakon uporabe potrebno je dezinficirati ruke i opremu.
English: Contact with disinfectants makes the vaccine ineffective.
Croatian: Kontakt s dezinficijensima čini cjepivo neučinkovitim.
English: Immunisation has to be considered as one component in a complex control program that addresses all important hygienic and health factors for poultry.
Croatian: Imunizaciju treba smatrati kao jednu od komponenti u složenom sustavu kontrole koja objedinjuje sve važne higijenske i zdravstvene čimbenike u peradarstvu.